Table 2.

Maximum Volume Reached, Time to Onset and Symptoms, Cumulative Incidence of BCRL^a

	Maximum Volume Reached (RVC)
	<5%	≥5%	≥10%
Median time to onset of max volume (mo)	–	11.48	16.86
Total no. of patients surveyed (N = 647b)	393 (60.7%)	254 (39.3%)	64 (9.9%)
No. of patients with reported symptoms (n = 547)	313 (79.6%)	234 (92.1%)	61 (95.3%)
Cumulative incidence of BRCL (no. progressions before timepoint)  12 mo  24 mo	–	22.1% (134) 36.4% (203)	4.0% (24) 8.2% (42)

^a BCRL = breast cancer-related lymphedema; RVC = relative volume change.

^b Row totals do not sum to these values because patients with RVC ≥ 10% are included in both the ≥10% and ≥5% columns.